Page last updated: 2024-08-24

cephalosporin c and fosfomycin

cephalosporin c has been researched along with fosfomycin in 62 studies

Research

Studies (62)

Timeframe	Studies, this research(%)	All Research%
pre-1990	8 (12.90)	18.7374
1990's	16 (25.81)	18.2507
2000's	14 (22.58)	29.6817
2010's	12 (19.35)	24.3611
2020's	12 (19.35)	2.80

Authors

Authors	Studies
Chico Rizzo, E	1
Triolo, R	1
Capri, S; Del Bono, GP; Dellamano, R	1
Akiyama, H; Arata, J; Kanzaki, H; Shimoe, K; Torigoe, R; Yamada, T	1
Traub, WH	1
Borner, K; Brückner, O; Collmann, H; Hoffmann, HG; Trautmann, M	1
Modaï, J	1
Ball, P; Chopra, I	1
Henkel, W; Krüger, C; Marre, R	1
Lindenschmidt, EG; Schassan, HH	1
Beloeil, H; Buisson, JC; Chavanet, P; Duigou, F; Duong, M; Kazmierczak, A; Neuwirth, C; Pechinot, A; Portier, H	1
Fukuchi, Y; Goto, H; Hayashi, I; Kudoh, S; Nakada, K; Oritsu, M; Sano, Y; Shimada, K; Shishido, H; Suzuki, H	1
Deguchi, K; Fukayama, S; Ishihara, R; Koguchi, M; Oda, S; Suzuki, K; Suzuki, Y; Yokota, N	1
Arakawa, K; Kono, K; Takeda, S; Tatara, I	1
Kouda, M	1
Nakagawa, Y; Toyoguchi, T	1
Martinez-Martinez, L; Pascual, A; Perea, EJ; Rodriguez, G; Suárez, AI	1
Quentin, C; Tessier, F	1
Kuriyama, T; Nakagawa, K; Saiki, Y; Yamamoto, E	1
Deguchi, K; Ishihara, R; Ishii, Y; Nakazawa, A; Suzuki, Y	1
Baquero, F; Cisterna, R; García-Rodríguez, JA; Gobernado, M; Liñares, F; Martín-Luengo, F; Piédrola, G; Trujillano Martín, I	1
Kubo, S; Moriguchi, N; Yagi, K; Yamamoto, T; Yoshioka, K	1
De La Rosa, G; Gleckman, R	1
Nakanishi, T; Nasu, T; Nishino, T; Okamoto, K	1
Hirai, K; Hiramatsu, K; Kishi, K; Murakami, J; Nasu, M; Yamasaki, T	1
Birnbaumer, D; Fernández-Frackelton, M	1
Awaya, Y; Doi, M; Ishihara, S; Ishioka, S; Kaneko, K; Karakawa, S; Kuwabara, M; Takao, S; Yamakido, M	1
Demesova, D; Hromec, J; Krcmery, S	1
Bañón Arias, R; García López, M; Pinedo Sánchez, A	1
Nicolle, LE	1
Haddad, JM; Pacetta, AM; Pinotti, JA; Ribeiro, RM; Rossi, P	1
Georgopoulos, A; Heinz, G; Joukhadar, C; Marsik, C; Müller, M; Zeitlinger, MA	1
Fariñas, MC; García-Palomo, D; Horcajada, JP	1
Akagi, S; Fukui, T; Isaka, M; Kano, M; Kurisu, Y; Matsumoto, K; Mizuno, I; Mouri, N; Nagasaki, T; Niitani, N; Shinagawa, N; Shinbara, K; Tagawa, K; Takeyama, H; Ueda, N; Watatani, Y; Yasuda, A; Yokoyama, T	1
Helmann, JD; Salzberg, LI	1
Eiros Bouza, JM; Ochoa Sangrador, C	1
Guitton, C; Koné-Paut, I; Milcent, K	1
Herrera, ML; Jorgensen, JH; Lewis, JS; Prakash, V; Wickes, BL	1
Falagas, ME; Gkegkes, ID; Kastoris, AC; Rafailidis, PI; Vouloumanou, EK	1
Fünfstück, R; Naber, KG; Olschläger, T; Wagenlehner, FM	1
Ben Khedher, S; Cheour, E; Kehila, M; Mahjoub, S; Majdoub, M; Zegha, D	1
Cheong, HJ; Cho, YK; Choi, TY; Chung, MH; Kang, JO; Ki, M; Kim, J; Kim, SJ; Kim, Y; Kwon, KT; Lee, H; Lee, JS; Lim, SK; Pai, H; Park, DW; Ryu, SY; Seo, MR; Wie, SH	1
Ahmad Murad, K; Chen, YT; Ng, LS; Park, JJ; Seah, JT; Tan, TY	1
Bai, L; Chen, Q; Fanning, S; Hurley, D; Li, F; Li, J; Wang, J; Wang, L; Yu, Z	1
Cerdeira, L; Cunha, MP; Dropa, M; Esposito, F; Franco, LS; Knöbl, T; Lincopan, N; Moreno, AM	1
Chan, EW; Chen, S; Wong, MH	1
Carratalà, J; Cuervo, G; Gudiol, C; Pujol, M; Shaw, E	1
Chakraborty, T; Fritzenwanker, M; Herold, S; Imirzalioglu, C; Wagenlehner, FM; Zimmer, KP	1
Avery, LM; Nicolau, DP; Sutherland, CA	1
Croxatto, A; Duss, FR; Garcia de la Mària, C; Giulieri, S; Lamoth, F; Manuel, O; Miró, JM	1
Avery, LM; Mullane, EM; Nicolau, DP	1
Kieffer, N; Mancini, S; Mueller, L; Nordmann, P; Poirel, L	1
Cayô, R; Cuba, GT; Gales, AC; Kiffer, CRV; Nicolau, DP; Nodari, CS; Pignatari, ACC; Rocha-Santos, G; Streling, AP	1
Abou Chakra, M; Dellis, A; Moussa, M; Moussa, Y; Papatsoris, A	1
Chusri, S; Ontong, JC; Ozioma, NF; Voravuthikunchai, SP	1
Bragantini, D; Carrara, E; Cattaneo, P; Chiamenti, M; Ellis, S; Franceschi, F; Giske, CG; Lodise, T; Menchinelli, G; Piddock, LJV; Righi, E; Sanguinetti, M; Savoldi, A; Scudeller, L; Tacconelli, E	1
Da Costa, RMA; Darlow, CA; Das, S; Ellis, S; Farrington, N; Franceschi, F; Hope, W; Jimenez-Valverde, A; Johnson, A; Kolamunnage-Dona, R; McEntee, L; Neely, M; Piddock, LJV; Sharland, M; Unsworth, J	1
Ishikawa, K	1
Suvorova, MP; Yakovlev, SV	1
Abat, D; Albaba, K; Gokalp, F; Gorur, S; Koras, O; Kulak, B; Sigva, H; Ucurmak, F; Yildirak, E	1
Huang, Q; Li, S; Lu, Y; Meng, X; Tan, W; Xu, Z; Zhang, Y; Zhu, Z	1
Albur, M; Attwood, M; Griffin, P; Macgowan, AP; Noel, AR	1

Reviews

13 review(s) available for cephalosporin c and fosfomycin

Article	Year
Transport of antibiotics into bacteria. Advances in microbial physiology, 1982, Volume: 23 Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteria; Biological Transport; Biological Transport, Active; Butylene Glycols; Cell Membrane; Cephalosporins; Chloramphenicol; Cycloserine; Energy Metabolism; Ferrous Compounds; Fosfomycin; Iron; Models, Biological; Organophosphonates; Penicillins; Peptides; Peptides, Cyclic; Peptidoglycan; Showdomycin; Streptozocin; Tetracyclines	1982
How do the newer oral antimicrobials stack up against traditional agents? Postgraduate medicine, 1998, Volume: 104, Issue:4 Topics: Administration, Oral; Anti-Bacterial Agents; Anti-Infective Agents; Cephalosporins; Fluoroquinolones; Fosfomycin; Humans; Infections; Macrolides; Patient Compliance; Tromethamine	1998
The new antibiotics. Emergency medicine clinics of North America, 2000, Volume: 18, Issue:4 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; Cephalosporins; Fluoroquinolones; Fosfomycin; Humans; Macrolides; Virginiamycin	2000
Urinary tract infection: traditional pharmacologic therapies. The American journal of medicine, 2002, Jul-08, Volume: 113 Suppl 1A Topics: Adolescent; Adult; Anti-Infective Agents, Urinary; Cephalosporins; Drug Resistance, Bacterial; Female; Fluoroquinolones; Fosfomycin; Humans; Middle Aged; Nitrofurantoin; Postmenopause; Pregnancy; Pregnancy Complications, Infectious; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections; Women's Health	2002
Therapy of uncomplicated urinary tract infections. International urogynecology journal and pelvic floor dysfunction, 2002, Volume: 13, Issue:3 Topics: 4-Quinolones; Anti-Infective Agents; Cephalosporins; Drug Administration Schedule; Female; Fosfomycin; Humans; Nitrofurantoin; Penicillins; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections	2002
[Treatment of uncomplicated lower urinary tract infections]. Enfermedades infecciosas y microbiologia clinica, 2005, Volume: 23 Suppl 4 Topics: Administration, Oral; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Cephalosporins; Cystitis; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Fosfomycin; Humans; Nitrofurantoin; Practice Guidelines as Topic; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections	2005
[Etiological profile of urinary tract infections and antimicrobial susceptibility of urinary pathogens]. Anales de pediatria (Barcelona, Spain : 2003), 2007, Volume: 67, Issue:5 Topics: Adult; Age Factors; Aminoglycosides; Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; Bacteria; Cephalosporins; Child; Child, Preschool; Clinical Trials as Topic; Consensus Development Conferences as Topic; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Evidence-Based Medicine; Fosfomycin; Hospitalization; Humans; Infant; Infant, Newborn; Microbial Sensitivity Tests; Risk Factors; Spain; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections	2007
[Urinary tract infections: cystitis, pyelonephritis, urosepsis]. Deutsche medizinische Wochenschrift (1946), 2012, Volume: 137, Issue:5 Topics: Anti-Infective Agents, Urinary; Bacteriuria; Cephalosporins; Chronic Disease; Cystitis; Drug Resistance, Bacterial; Fluoroquinolones; Fosfomycin; Humans; Microbial Sensitivity Tests; Nitrofurantoin; Pyelonephritis; Recurrence; Risk Factors; Sepsis; Tromethamine; Urinary Tract Infections	2012
Pharmacotherapeutic options for treating Staphylococcus aureus bacteremia. Expert opinion on pharmacotherapy, 2017, Volume: 18, Issue:18 Topics: Anti-Bacterial Agents; Bacteremia; Cefazolin; Cephalosporins; Drug Therapy, Combination; Fosfomycin; Glycopeptides; Humans; Methicillin-Resistant Staphylococcus aureus; Penicillins; Staphylococcal Infections; Staphylococcus aureus	2017
Treatment Options for Carbapenem- Resistant Gram-Negative Infections. Deutsches Arzteblatt international, 2018, 05-21, Volume: 115, Issue:20-21 Topics: Aminoglycosides; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Ceftazidime; Cephalosporins; Colistin; Drug Therapy, Combination; Escherichia coli; Fluoroquinolones; Fosfomycin; Germany; Gram-Negative Bacteria; Humans; Klebsiella pneumoniae; Piperacillin; Pseudomonas aeruginosa; Tigecycline	2018
Pharmacotherapeutic advances for recurrent urinary tract infections in women. Expert opinion on pharmacotherapy, 2020, Volume: 21, Issue:16 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Beverages; Ceftazidime; Cephalosporins; Drug Combinations; Female; Fosfomycin; Humans; Recurrence; Secondary Prevention; Tazobactam; Urinary Tract Infections; Vaccinium macrocarpon	2020
Systematic review and meta-analysis of in vitro efficacy of antibiotic combination therapy against carbapenem-resistant Gram-negative bacilli. International journal of antimicrobial agents, 2021, Volume: 57, Issue:5 Topics: Amikacin; Anti-Bacterial Agents; Azabicyclo Compounds; Carbapenems; Ceftazidime; Cephalosporins; Colistin; Drug Combinations; Drug Resistance, Bacterial; Drug Synergism; Drug Therapy, Combination; Fosfomycin; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; In Vitro Techniques; Microbial Sensitivity Tests; Polymyxins; Rifampin; Tazobactam; Tobramycin	2021
[Rationale for choosing an antibiotic for the treatment of cystitis: recommendations of clinical pharmacologists: A review]. Terapevticheskii arkhiv, 2022, Oct-12, Volume: 94, Issue:8 Topics: Anti-Bacterial Agents; Cephalosporins; Cystitis; Escherichia coli; Fluoroquinolones; Fosfomycin; Humans; Nitrofurans; Nitrofurantoin; Potassium; Tromethamine; Urinary Tract Infections	2022

Trials

3 trial(s) available for cephalosporin c and fosfomycin

Article	Year
[Clinical usefulness of the combined empirical therapy with flomoxef and fosfomycin for intractable respiratory tract infections. With a background of increasing MRSA incidence]. The Japanese journal of antibiotics, 1994, Volume: 47, Issue:10 Topics: Aged; Aged, 80 and over; Bacterial Infections; Cephalosporins; Drug Therapy, Combination; Female; Fosfomycin; Humans; Incidence; Japan; Male; Methicillin Resistance; Middle Aged; Respiratory Tract Infections; Staphylococcal Infections; Staphylococcus aureus	1994
Treatment of lower urinary tract infection in pregnancy. International journal of antimicrobial agents, 2001, Volume: 17, Issue:4 Topics: Adult; Anti-Infective Agents, Urinary; Bacteriuria; Cephalosporins; Enterobacteriaceae Infections; Female; Fosfomycin; Humans; Penicillins; Pregnancy; Pregnancy Complications, Infectious; Prevalence; Risk Factors; Staphylococcal Infections	2001
[Prophylactic effect of fosfomycin on postoperative infection in gastroenterological surgery]. The Japanese journal of antibiotics, 2006, Volume: 59, Issue:6 Topics: Adolescent; Adult; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacterial Infections; Biliary Tract Surgical Procedures; Cefmetazole; Cephalosporins; Digestive System Surgical Procedures; Drug Administration Schedule; Female; Fosfomycin; Humans; Infusions, Intravenous; Male; Middle Aged; Postoperative Complications; Prospective Studies; Treatment Outcome	2006

Other Studies

46 other study(ies) available for cephalosporin c and fosfomycin

Article	Year
Antibiotic treatment of respiratory sepsis. Antibiotics and chemotherapy, 1976, Volume: 21 Topics: Ampicillin; Anti-Bacterial Agents; Carbenicillin; Cephalosporins; Chloramphenicol; Cloxacillin; Fosfomycin; Gentamicins; Haemophilus Infections; Humans; Methicillin; Penicillin G; Polymyxins; Pseudomonas Infections; Respiratory Tract Infections; Sepsis; Staphylococcal Infections; Streptococcal Infections	1976
[Nephrotoxicity of antibiotics]. Minerva medica, 1976, May-09, Volume: 67, Issue:23 Topics: Aminoglycosides; Anti-Bacterial Agents; Antibiotics, Antineoplastic; Antifungal Agents; Cephalosporins; Chloramphenicol; Erythromycin; Fosfomycin; Humans; Kidney Diseases; Penicillins; Peptides; Rifampin; Tetracyclines	1976
Cost-effectiveness comparison of single and multiple-dose antibiotic treatment of lower uncomplicated urinary tract infections. Journal of chemotherapy (Florence, Italy), 1992, Volume: 4, Issue:3 Topics: Adult; Anti-Bacterial Agents; Cephalosporins; Cost-Benefit Analysis; Drug Administration Schedule; Drug Therapy, Combination; Female; Fosfomycin; Humans; Piperacillin; Time Factors; Tromethamine; Urinary Tract Infections	1992
[Combination effects of fosfomycin and other oral antimicrobial agents against methicillin-resistant Staphylococcus aureus]. Nihon Hifuka Gakkai zasshi. The Japanese journal of dermatology, 1990, Volume: 100, Issue:12 Topics: Administration, Oral; Cephalosporins; Doxycycline; Drug Therapy, Combination; Erythromycin; Fosfomycin; Humans; Methicillin Resistance; Minocycline; Skin; Skin Diseases, Infectious; Staphylococcus aureus	1990
Clostridium perfringens type A. Comparison of in vitro and in vivo activity of twelve antimicrobial drugs. Chemotherapy, 1986, Volume: 32, Issue:1 Topics: Animals; Anti-Bacterial Agents; Cephalosporins; Clostridium perfringens; Fosfomycin; Gas Gangrene; Imipenem; Metronidazole; Mice; Microbial Sensitivity Tests; Oxacillin; Penicillin G; Thienamycins; Vancomycin	1986
[Current aspects of pseudomonas meningitis]. Neurochirurgia, 1985, Volume: 28, Issue:1 Topics: Aminoglycosides; Anti-Bacterial Agents; Azlocillin; Bacteriological Techniques; Brain Injuries; Cefsulodin; Cephalosporins; Diagnosis, Differential; Fosfomycin; Humans; Meningitis; Penicillins; Polymyxins; Pseudomonas Infections	1985
[Therapeutic contribution of recently marketed antibiotics]. La Revue du praticien, 1985, Mar-11, Volume: 35, Issue:15 Topics: Anti-Bacterial Agents; Cephalosporins; Fosfomycin; Humans; Nalidixic Acid; Netilmicin; Pefloxacin	1985
[Chemotherapy with fosfomycin, cefoxitin, and cefotaxime in experimental E. coli-pleuropneumonia (author's transl)]. Immunitat und Infektion, 1981, Volume: 9, Issue:1 Topics: Animals; Anti-Bacterial Agents; Cefotaxime; Cefoxitin; Cephalosporins; Dose-Response Relationship, Drug; Escherichia coli Infections; Female; Fosfomycin; Kinetics; Pleuropneumonia; Rats	1981
[Fosfomycin, a new antibiotic: in vitro activity compared with mezlocillin, cefuroxime and gentamicin]. Immunitat und Infektion, 1980, Volume: 8, Issue:4 Topics: Animals; Anti-Bacterial Agents; Cefuroxime; Cephalosporins; Enterobacteriaceae; Fosfomycin; Gentamicins; In Vitro Techniques; Mezlocillin; Penicillin Resistance; Penicillins; Pseudomonadaceae; Staphylococcus	1980
In vivo activity and pharmacodynamics of cefotaxime or ceftriaxone in combination with fosfomycin in fibrin clots infected with highly penicillin-resistant Streptococcus pneumoniae. Antimicrobial agents and chemotherapy, 1995, Volume: 39, Issue:8 Topics: Animals; Cefotaxime; Ceftriaxone; Cephalosporin Resistance; Cephalosporins; Drug Therapy, Combination; Fibrin; Fosfomycin; Male; Microbial Sensitivity Tests; Multivariate Analysis; Rabbits; Streptococcus pneumoniae	1995
[Antibiotic efficacies of combined uses of arbekacin and various antibiotics against methicillin-resistant Staphylococcus aureus]. The Japanese journal of antibiotics, 1994, Volume: 47, Issue:6 Topics: Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Dibekacin; Drug Therapy, Combination; Fosfomycin; Imipenem; Methicillin Resistance; Microbial Sensitivity Tests; Penicillins; Staphylococcus aureus	1994
In vitro activities of arbekacin, alone and in combination, against methicillin-resistant Staphylococcus aureus. The Japanese journal of antibiotics, 1994, Volume: 47, Issue:6 Topics: Aminoglycosides; Anti-Bacterial Agents; Cefotiam; Ceftizoxime; Cephalosporins; Dibekacin; Drug Therapy, Combination; Fosfomycin; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Staphylococcus aureus	1994
[In vitro effects of combinations of antibiotics against highly-fosfomycin-resistant, methicillin-resistant Staphylococcus aureus. With special reference to efficacies of combinations of imipenem/cilastatin and cephems]. The Japanese journal of antibiotics, 1993, Volume: 46, Issue:2 Topics: Cephalosporins; Cilastatin; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Fosfomycin; Imipenem; Methicillin Resistance; Staphylococcus aureus	1993
[Nephrotoxicity and drug interaction of vancomycin (2)]. Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 1996, Volume: 107, Issue:5 Topics: Animals; Blood Urea Nitrogen; Cefoperazone; Ceftazidime; Cephalosporins; Cilastatin; Cilastatin, Imipenem Drug Combination; Creatinine; Drug Combinations; Drug Interactions; Drug Therapy, Combination; Fosfomycin; Imipenem; Kidney; Male; Organ Size; Rabbits; Vancomycin	1996
In-vitro activity of antimicrobial agent combinations against multiresistant Acinetobacter baumannii. The Journal of antimicrobial chemotherapy, 1996, Volume: 38, Issue:6 Topics: Acinetobacter; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Ceftazidime; Cephalosporins; Ciprofloxacin; Drug Resistance, Multiple; Drug Therapy, Combination; Fosfomycin; Imipenem; Microbial Sensitivity Tests; Thienamycins; Tobramycin	1996
In vitro activity of fosfomycin combined with ceftazidime, imipenem, amikacin, and ciprofloxacin against Pseudomonas aeruginosa. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1997, Volume: 16, Issue:2 Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Ceftazidime; Cephalosporins; Ciprofloxacin; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Fosfomycin; Imipenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Thienamycins	1997
[A case of severe odontogenic infection with allergic skin reaction for beta-lactam antibiotics]. Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases, 1997, Volume: 71, Issue:5 Topics: Adult; Anti-Bacterial Agents; Cellulitis; Cephalosporins; Clindamycin; Drug Eruptions; Drug Therapy, Combination; Female; Fosfomycin; Humans; Levofloxacin; Ofloxacin; Periapical Abscess	1997
[The drug susceptibility pattern of the presumed etiologic agents of infectious enteritis including verotoxin-producing Escherichia coli O-157]. The Japanese journal of antibiotics, 1997, Volume: 50, Issue:10 Topics: Aerobiosis; Ampicillin; Anaerobiosis; Anti-Bacterial Agents; Anti-Infective Agents; Campylobacter jejuni; Cefaclor; Cephalosporins; Chloramphenicol; Drug Resistance, Microbial; Enteritis; Escherichia coli O157; Fosfomycin; Humans; Microbial Sensitivity Tests; Minocycline; Norfloxacin; Penicillins; Salmonella; Tetracycline; Vibrio parahaemolyticus	1997
In vitro activity of fosfomycin trometamol against pathogens from urinary tract infections: a Spanish multicenter study. Journal of chemotherapy (Florence, Italy), 1997, Volume: 9, Issue:6 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Cephalosporins; Drug Resistance, Microbial; Drug Therapy, Combination; Enterobacteriaceae; Excipients; Fosfomycin; Gram-Negative Bacteria; Gram-Positive Bacteria; Guidelines as Topic; Humans; Microbial Sensitivity Tests; Norfloxacin; Spain; Tromethamine; Urinary Tract Infections	1997
[The drug sensitivity of enterohemorragic Escherichia coli and antibiotics treatment for hemorrhagic enterocolitis--from an outbreak of enterocolitis in Sakai city]. The Japanese journal of antibiotics, 1997, Volume: 50, Issue:7 Topics: Administration, Oral; Ampicillin; Anti-Bacterial Agents; Cefaclor; Cephalosporins; Child; Disease Outbreaks; Drug Resistance, Microbial; Enterocolitis; Escherichia coli Infections; Escherichia coli O157; Fosfomycin; Humans; Japan; Kanamycin; Penicillins	1997
[In vitro antibacterial activity of faropenem, a novel oral penem antibiotic, against enterohemorrhagic Escherichia coli O157 strains]. The Japanese journal of antibiotics, 1999, Volume: 52, Issue:8 Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; Bacterial Toxins; beta-Lactams; Cefdinir; Cephalosporins; Clarithromycin; Escherichia coli O157; Fosfomycin; Kanamycin; Lactams; Microbial Sensitivity Tests; Minocycline; Norfloxacin; Shiga Toxin 1	1999
Macrolides and clindamycin suppress the release of Shiga-like toxins from Escherichia coli O157:H7 in vitro. International journal of antimicrobial agents, 2000, Volume: 15, Issue:2 Topics: Animals; Anti-Bacterial Agents; Bacterial Toxins; Cefdinir; Cephalosporins; Chlorocebus aethiops; Clindamycin; Dose-Response Relationship, Drug; Escherichia coli O157; Fosfomycin; Humans; Latex Fixation Tests; Levofloxacin; Microbial Sensitivity Tests; Miocamycin; Ofloxacin; Roxithromycin; Shiga Toxin 1; Shiga Toxin 2; Time Factors; Vero Cells	2000
Two cases of severe bronchopneumonia due to influenza A (H3N2) virus: detection of influenza virus gene using reverse transcription polymerase chain reaction. Internal medicine (Tokyo, Japan), 2001, Volume: 40, Issue:1 Topics: Aged; Antibiotic Prophylaxis; Betamethasone; Bronchoalveolar Lavage Fluid; Bronchopneumonia; Cephalosporins; Clindamycin; Combined Modality Therapy; Drug Therapy, Combination; Fosfomycin; Humans; Influenza A virus; Influenza A Virus, H3N2 Subtype; Male; Methylprednisolone; Middle Aged; Minocycline; Pneumonia, Viral; Positive-Pressure Respiration; Respiration, Artificial; Reverse Transcriptase Polymerase Chain Reaction; RNA, Viral	2001
Time-kill evaluation of antimicrobial regimens against clinical isolates of penicillin-resistant Streptococcus pneumoniae. Journal of chemotherapy (Florence, Italy), 2001, Volume: 13, Issue:5 Topics: Anti-Bacterial Agents; Ceftriaxone; Cephalosporins; Drug Interactions; Drug Therapy, Combination; Fosfomycin; Kinetics; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Pneumococcal Infections; Streptococcus pneumoniae; Vancomycin	2001
Target site bacterial killing of cefpirome and fosfomycin in critically ill patients. International journal of antimicrobial agents, 2003, Volume: 21, Issue:6 Topics: Anti-Bacterial Agents; Cefpirome; Cephalosporins; Colony Count, Microbial; Drug Therapy, Combination; Fosfomycin; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Shock, Septic; Staphylococcus aureus	2003
An antibiotic-inducible cell wall-associated protein that protects Bacillus subtilis from autolysis. Journal of bacteriology, 2007, Volume: 189, Issue:13 Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacillus subtilis; Bacitracin; Bacterial Proteins; Bacteriolysis; Base Sequence; Carrier Proteins; Cell Wall; Cephalosporins; Cycloserine; Drug Resistance, Bacterial; Fosfomycin; Gene Expression Regulation, Bacterial; Molecular Sequence Data; Mutation; N-Acetylmuramoyl-L-alanine Amidase; Sequence Alignment; Succinate Dehydrogenase; Time Factors; Vancomycin	2007
[French nationwide survey about management of acute osteomyelitis in children]. Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 2009, Volume: 16, Issue:1 Topics: Acute Disease; Administration, Oral; Age Factors; Aminoglycosides; Anti-Bacterial Agents; Bone and Bones; Cephalosporins; Child; Child, Preschool; Data Collection; Drug Therapy, Combination; Follow-Up Studies; Fosfomycin; France; Hospitalization; Humans; Infant; Injections, Intravenous; Orthopedics; Osteomyelitis; Pediatrics; Penicillins; Pristinamycin; Radiography; Radionuclide Imaging; Surveys and Questionnaires; Time Factors; Treatment Outcome	2009
Oral and parenteral therapeutic options for outpatient urinary infections caused by enterobacteriaceae producing CTX-M extended-spectrum beta-lactamases. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:3 Topics: Administration, Oral; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cefdinir; Cephalosporins; Cross Infection; Enterobacteriaceae; Ertapenem; Escherichia coli; Fosfomycin; Humans; Infusions, Parenteral; Microbial Sensitivity Tests; Outpatients; Urinary Tract Infections	2009
Synergy of fosfomycin with other antibiotics for Gram-positive and Gram-negative bacteria. European journal of clinical pharmacology, 2010, Volume: 66, Issue:4 Topics: Acinetobacter baumannii; Amikacin; Anti-Bacterial Agents; Bacteria; Cefepime; Ceftazidime; Cephalosporins; Ciprofloxacin; Enterobacteriaceae; Fosfomycin; Gentamicins; Gram-Negative Bacteria; Methicillin Resistance	2010
[Pubic symphysite of postpartum: a difficult diagnosis]. The Pan African medical journal, 2013, Volume: 16 Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Infectious; Cephalosporins; Diagnosis, Differential; Female; Fosfomycin; Humans; Pregnancy; Pubic Symphysis; Puerperal Disorders; Streptococcal Infections	2013
Susceptibility of Escherichia coli from community-acquired urinary tract infection to fosfomycin, nitrofurantoin, and temocillin in Korea. Journal of Korean medical science, 2014, Volume: 29, Issue:8 Topics: Anti-Bacterial Agents; Cefepime; Cell Survival; Cephalosporins; Ciprofloxacin; Community-Acquired Infections; Dose-Response Relationship, Drug; Drug Combinations; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Fosfomycin; Humans; Nitrofurantoin; Penicillins; Republic of Korea; Sulfadoxine; Treatment Outcome; Trimethoprim; Urinary Tract Infections	2014
In Vitro Efficacy of Six Alternative Antibiotics against Multidrug Resistant Escherichia Coli and Klebsiella Pneumoniae from Urinary Tract Infections. Annals of the Academy of Medicine, Singapore, 2016, Volume: 45, Issue:6 Topics: Amdinocillin; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cefpodoxime; Ceftibuten; Ceftizoxime; Cephalosporins; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Fosfomycin; Genotype; Humans; In Vitro Techniques; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Multiplex Polymerase Chain Reaction; Penicillins; Singapore; Trimethoprim; Urinary Tract Infections	2016
A novel disrupted mcr-1 gene and a lysogenized phage P1-like sequence detected from a large conjugative plasmid, cultured from a human atypical enteropathogenic Escherichia coli (aEPEC) recovered in China. The Journal of antimicrobial chemotherapy, 2017, 05-01, Volume: 72, Issue:5 Topics: Anti-Bacterial Agents; Bacteriophage P1; Cephalosporins; China; Colistin; Conjugation, Genetic; DNA Transposable Elements; Drug Resistance, Bacterial; Enteropathogenic Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Fosfomycin; Humans; Lysogeny; Male; Plasmids; Sequence Analysis, DNA	2017
Coexistence of CTX-M-2, CTX-M-55, CMY-2, FosA3, and QnrB19 in Extraintestinal Pathogenic Escherichia coli from Poultry in Brazil. Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:4 Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; Brazil; Cephalosporins; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Proteins; Fosfomycin; Poultry; Quinolones	2017
IS26-mediated formation of a virulence and resistance plasmid in Salmonella Enteritidis. The Journal of antimicrobial chemotherapy, 2017, 10-01, Volume: 72, Issue:10 Topics: Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; DNA Transposable Elements; Drug Resistance, Multiple, Bacterial; Escherichia coli; Fosfomycin; Humans; Microbial Sensitivity Tests; Plasmids; Salmonella enteritidis; Salmonella Infections; Sequence Analysis, DNA; Virulence	2017
Prevalence of in vitro synergistic antibiotic interaction between fosfomycin and nonsusceptible antimicrobials in carbapenem-resistant Pseudomonas aeruginosa. Journal of medical microbiology, 2019, Volume: 68, Issue:6 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azabicyclo Compounds; Carbapenems; Ceftazidime; Cephalosporins; Drug Combinations; Drug Resistance, Bacterial; Drug Synergism; Fosfomycin; Humans; Meropenem; Prevalence; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam; Tobramycin; United States	2019
Successful treatment with daptomycin and ceftaroline of MDR Staphylococcus aureus native valve endocarditis: a case report. The Journal of antimicrobial chemotherapy, 2019, 09-01, Volume: 74, Issue:9 Topics: Aged, 80 and over; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Community-Acquired Infections; Daptomycin; Drug Synergism; Endocarditis; Fosfomycin; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcal Infections	2019
Comparative Evaluation of the Antimicrobial agents and chemotherapy, 2020, 02-21, Volume: 64, Issue:3 Topics: Amikacin; Anti-Bacterial Agents; Azabicyclo Compounds; Cephalosporins; Cyclooctanes; Drug Resistance, Multiple, Bacterial; Fosfomycin; Microbial Sensitivity Tests; Pseudomonas aeruginosa	2020
IS Antimicrobial agents and chemotherapy, 2020, 04-21, Volume: 64, Issue:5 Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cephalosporins; DNA Transposable Elements; Drug Resistance, Multiple, Bacterial; Fosfomycin; Genome, Bacterial; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Mutagenesis, Insertional; Transcription Factors; Whole Genome Sequencing	2020
In vitro synergy of ceftolozane/tazobactam in combination with fosfomycin or aztreonam against MDR Pseudomonas aeruginosa. The Journal of antimicrobial chemotherapy, 2020, 07-01, Volume: 75, Issue:7 Topics: Anti-Bacterial Agents; Aztreonam; Cephalosporins; Fosfomycin; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam	2020
Synergistic antibacterial effects of colistin in combination with aminoglycoside, carbapenems, cephalosporins, fluoroquinolones, tetracyclines, fosfomycin, and piperacillin on multidrug resistant Klebsiella pneumoniae isolates. PloS one, 2021, Volume: 16, Issue:1 Topics: Aminoglycosides; Anti-Bacterial Agents; Carbapenems; Cephalosporins; Colistin; Drug Resistance, Multiple, Bacterial; Drug Synergism; Fluoroquinolones; Fosfomycin; Klebsiella pneumoniae; Piperacillin; Tetracyclines	2021
Flomoxef and fosfomycin in combination for the treatment of neonatal sepsis in the setting of highly prevalent antimicrobial resistance. The Journal of antimicrobial chemotherapy, 2022, 04-27, Volume: 77, Issue:5 Topics: Anti-Bacterial Agents; Cephalosporins; Drug Resistance, Bacterial; Fosfomycin; Humans; Infant, Newborn; Microbial Sensitivity Tests; Neonatal Sepsis	2022
Editorial Comment to Efficacy of fosfomycin in preventing infection after endoscopic combined intrarenal surgery in periods of limited supply of first- and second-generation cephalosporins. International journal of urology : official journal of the Japanese Urological Association, 2022, Volume: 29, Issue:9 Topics: Anti-Bacterial Agents; Cephalosporins; Endoscopy; Fosfomycin; Humans; Kidney Calculi; Nephrostomy, Percutaneous	2022
Single-dose fosfomycin could prevent infectious complications after retrograde intrarenal surgery: A prospective study. Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie, 2023, Volume: 33, Issue:3 Topics: Cephalosporins; Fosfomycin; Humans; Kidney Calculi; Lithotripsy; Monobactams; Postoperative Complications; Prospective Studies; Retrospective Studies; Treatment Outcome; Urinary Tract Infections	2023
Cotransfer of resistance to cephalosporins, colistin, and fosfomycin mediated by an IncHI2/pSH16G4928-like plasmid in ESBL-producing monophasic Salmonella Typhimurium strains of pig origin. Journal of applied microbiology, 2023, Mar-01, Volume: 134, Issue:3 Topics: Animals; Anti-Bacterial Agents; Cephalosporins; Colistin; Escherichia coli; Escherichia coli Proteins; Fosfomycin; Microbial Sensitivity Tests; Plasmids; Salmonella typhimurium; Swine	2023
Antibacterial effect of seven days exposure to ceftolozane-tazobactam as monotherapy and in combination with fosfomycin or tobramycin against Pseudomonas aeruginosa with ceftolozane-tazobactam MICs at or above 4 mg/l in an in vitro pharmacokinetic model. The Journal of antimicrobial chemotherapy, 2023, 09-05, Volume: 78, Issue:9 Topics: Anti-Bacterial Agents; Cephalosporins; Fosfomycin; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam; Tobramycin	2023